TNFSF10 and breast carcinoma: These findings validated the promising anticancer effect of TQ+TRAIL in breast cancer MCF-7 and MDA-MB-231 cells based on protein content (SRB test), which is consistent with our recently published paper that found similar results but used mitochondrial MTT labelling instead of SRB staining (Abd El-Salam et al., 2021).